Detalhe da pesquisa
1.
Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.
Cardiovasc Diabetol
; 18(1): 35, 2019 03 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30885203
2.
Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats.
Cells
; 12(4)2023 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36831332
3.
Expression of placental CD146 is dysregulated by prenatal alcohol exposure and contributes in cortical vasculature development and positioning of vessel-associated oligodendrocytes.
Front Cell Neurosci
; 17: 1294746, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38269113
4.
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury.
J Adv Res
; 43: 163-174, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36585106
5.
Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?
Metabolites
; 11(11)2021 Nov 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34822442
6.
Beneficial Effects of Remifentanil Against Excitotoxic Brain Damage in Newborn Mice.
Front Neurol
; 10: 407, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31068895
7.
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
J Med Chem
; 62(18): 8443-8460, 2019 09 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31436984
8.
Multiple and Opposite Effects of Angiotensin II Receptor Blockers on the Bioavailability of Epoxyeicosatrienoic Acids.
Basic Clin Pharmacol Toxicol
; 121(4): 213-214, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28639405